Rainbow Extension Study
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Ranibizumab
Related studies linked through entity extraction aliases.
CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab
- Status
- WITHDRAWN
- Phase
- PHASE4
Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE3
Head to Head Study of Anti-VEGF Treatment.
- Status
- COMPLETED
- Phase
- PHASE4
Study of DS-7080a for the Treatment of Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE1
Retinal Sensitivity in BRVO After Anti-VEGF Therapy
- Status
- UNKNOWN
- Phase
- PHASE4
Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas
- Status
- UNKNOWN
- Phase
- PHASE4
Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration
- Status
- WITHDRAWN
- Phase
- PHASE2
Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE2
A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE4
A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE3
To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE4
25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial
- Status
- UNKNOWN
- Phase
- PHASE3
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
- Status
- TERMINATED
- Phase
- PHASE2
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
- Status
- COMPLETED
- Phase
- PHASE3
Geographic Atrophy and Intravitreal Ranibizumab Injections
- Status
- UNKNOWN
- Phase
- N/A